Company Overview - SS Innovations International, Inc. (NASDAQ:SSII) is focused on advancing affordable surgical robotics with its flagship SSi Mantra system, which provides a cost-efficient alternative to established platforms like Intuitive Surgical's da Vinci [2] - The SSi Mantra system has received approval in seven countries, including India, Indonesia, and the Philippines, and the company is seeking regulatory approval in the U.S. and Europe to expand its market presence [2] Financial Performance - In Q2 2025, SS Innovations International, Inc. reported a revenue increase of 121.8% to $10 million, with gross profit more than tripling year-over-year [4] - The installations of the SSi Mantra system grew by 130% year-over-year, resulting in a total installed base of 105 systems that have performed 4,657 surgeries as of June 30, 2025 [4] Leadership Changes - Naveen Kumar Amar was appointed as Chief Financial Officer in September 2025, bringing extensive international finance experience as the company prepares for increased sales and regulatory submissions [3] Technological Achievements - The company achieved a significant milestone by performing the world's first intercontinental robotic cardiac telesurgery in July 2025, showcasing its advanced technological capabilities [4]
SS Innovations International, Inc. (SSII)’s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery